Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Prospective, Randomized, Parallel Group, Open-label Design to Determine the Efficacy and Safety of Endovascular Thrombectomy for Ischemic Stroke Patients With Symptomatic Acute Medium Vessel Intracranial Occlusions

NCT05151172 is registered in ClinicalTrials.gov with Dr. Michael D Hill as lead sponsor.

NCT NCT05151172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05151172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Prospective, Randomized, Parallel Group, Open-label Design to Determine the Efficacy and Safety of Endovascular Thrombectomy for Ischemic Stroke Patients With Symptomatic Acute Medium Vessel Intracranial Occlusions
Lead sponsor
Dr. Michael D Hill
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 15, 2022
Completion date
June 30, 2026
Enrollment
530 (estimated)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke